Loading stock data…
Aflac Incorporated (AFL)
$119.66-0.50 (-0.41%)
Market OpenUpdated 2:08 PM EDT
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Aflac Incorporated in the Financial Services sector is trading at $119.66 with a market capitalization of $59.8B. Wall Street consensus targets $112.43 (14 analysts), implying a -6.0% move over the next 12 months. The stock is currently near its 52-week high of $120.28, remaining 8.0% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply -6.0% downside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $4.41B↓ | $4.89B↑ | $4.79B↑ | $4.22B↑ | $3.45B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $1.28B↓ | $1.63B↓ | $2.05B↑ | $874.00M↑ | $195.00M |
| Net Income | $1.02B↓ | $1.38B↓ | $1.64B↑ | $599.00M↑ | $29.00M |
Peer Comparison
JPMBACGS
Fundamentals
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insuran...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$59.81B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
1.48%
ROE
Elite ROE. Management converts capital into profit efficiently.
15.47%
Volume
Today's trading volume
531,556
Recent News
Trupanion (TRUP) Moves 5.8% Higher: Will This Strength Last?
Trupanion (TRUP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
UNM Outperforms Industry, Trades Near 52-Week High: Time to Exit?
Unum Group targets higher premiums and earnings in 2026, supported by sales momentum, technology investments and capital strength.
MarketBeat Week in Review – 06/08 - 06/12
Stocks rallied on optimism surrounding a potential U.S.-Iran peace deal and SpaceX's historic IPO debut, reinforcing investor confidence and market momentum
The “Duck Stock” Keeps Quietly Making Money for Shareholders
Aflac stock continues delivering reliable returns through dividends, buybacks, and supplemental insurance growth despite limited short-term upside potential.
How Aflac (AFL) Investors Can Read A Steady Target And Evolving Company Story
Aflac’s latest analyst update keeps the price target unchanged, with no revisions to the previous level. Even without a new price target or fresh commentary, the stability itself gives you a reference point for how the stock is currently being framed in analyst models. Read on to see how to interpret this kind of steady outlook and how to keep tracking the evolving narrative around Aflac. Stay updated as the Fair Value for Aflac shifts by adding it to your watchlist or portfolio...